Primer: Glenmark Pharmaceuticals (GNP IN) - Aug 2026
Financial Turnaround and Growth Momentum: The company has demonstrated a significant financial turnaround, moving from a net loss in FY24 to...
96 Views
𝛼SK or SearchENTITY
Glenmark Pharmaceuticals (GNP IN)
Glenmark Pharmaceuticals (GNP IN)
183
Analysis
Health Care • India
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company that develops, manufactures, and markets branded and generic formulations, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) products. The company focuses on therapeutic areas including respiratory, dermatology, and oncology, with products such as Ryaltris, Winlevi, and Candid. It was founded in 1977 and is headquartered in Mumbai, India.
morex